BTC Health Stock

BTC Health FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of BTC Health (BTC.AX) as of Sep 4, 2026 is -12.56 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -38.36 % — a change of -67.26% (higher).

FCF Conversion

-12.56 %

YoY

-67.26%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of BTC Health is 2026 -12.56 % . FCF Conversion Rate (FCF/EBITDA) of BTC Health was 2025 -38.36 % . It decreases by -67.26% higher compared to the previous year.

The BTC Health FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
37.85 AUD
Jan 1, 2019
94.67 AUD
Jan 1, 2020
173.85 AUD
Jan 1, 2021
93.46 AUD
Jan 1, 2022
68.20 AUD
Jan 1, 2023
4.26 AUD
Jan 1, 2024
-38.36 AUD
Jan 1, 2025
-12.56 AUD
The BTC Health FCF Conversion history
YEARFCF ConversionYoY
-12.56 %-67.26%
-38.36 %-999.51%
4.26 %-93.75%
68.20 %-27.03%
93.46 %-46.24%
173.85 %+83.63%
94.67 %+150.15%
37.85 %-49.67%
75.20 %+302.48%
18.68 %-54.89%
41.42 %+421.89%
7.94 %
Access this data via the Eulerpool API

BTC Health Stock analysis

What does BTC Health do? BTC Health Ltd is a British company specializing in the production and distribution of medical devices and pharmaceuticals. The company was founded in 2005 and is headquartered in London. Business model BTC Health Ltd's business model is based on the manufacturing and distribution of medical devices and pharmaceuticals that meet the highest quality standards. The company works closely with medical professionals and research institutions to develop innovative products that meet the needs of patients and healthcare providers. Divisions BTC Health Ltd is divided into several divisions, each offering different products and services. The main divisions are: - Medical Technology - Diagnostics - Pharmaceuticals Medical Technology The Medical Technology division manufactures a wide range of medical devices, including ventilators, infusion pumps, defibrillators, and patient monitors. These devices are used in hospitals, clinics, and care facilities to accurately monitor and treat patients. Diagnostics The Diagnostics division offers a variety of laboratory and diagnostic products, including blood glucose monitors, test strips, immunassays, and ELISA kits. These products are used for the rapid and reliable identification of diseases, enabling effective treatment. Pharmaceuticals The Pharmaceuticals division specializes in the production and distribution of innovative pharmaceuticals specifically developed for the treatment of rare diseases and serious illnesses. Products include cancer medications, antibody therapeutics, and treatments for rare metabolic disorders. Products BTC Health Ltd offers a wide range of medical devices and pharmaceuticals that meet the highest quality standards. Some of the key products include: - VasoPress (medication for the treatment of low blood pressure) - Episcan (ultrasound device for early detection of breast cancer) - Novotest (test for diagnosing kidney dysfunction) - Bongo (infusion pump for medication dosing) - Nonin Xpod (patient monitor for monitoring vital signs) Conclusion BTC Health Ltd is a leading company in the production and distribution of medical devices and pharmaceuticals. The company is committed to developing innovative products that meet the needs of patients and healthcare providers. With a wide range of products in various divisions, BTC Health Ltd is well positioned to be an important partner in the healthcare industry in the future. BTC Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BTC Health stock

FCF Conversion Rate (FCF/EBITDA) of BTC Health is -12.56 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of BTC Health changed from -38.36 % to -12.56 %, representing a -67.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) BTC Health since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s BTC Health with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — BTC Health

All Key Metrics — BTC Health